Skip to main content

UK Grants Nearly $6M for North/East England High-throughput Hubs

NEW YORK (GenomeWeb News) — The United Kingdom has granted a total of £3.9 million ($5.8 million) to the University of Liverpool and to the Babraham Institute to start two high-throughput genomics hubs as part of a three-prong program to enhance the country's DNA sequencing resources.

The University of Liverpool will use £2.2 million ($3.3 million) from the Medical Research Council (MRC) and the Northwest Regional Development Agency to establish a high-throughput genomic analysis hub in the North of England as part of an effort to increase the nation's genomics resources and to advance academic medical science, the university said today.

£2 million came from the MRC and £200,000 came from the Northwest Regional Development Agency. The initiative is part of a £7 million effort to support hubs in North and East England, and in Scotland.

These high-throughput centers will be available for use by all academic researchers in the UK.

This Northern hub will consolidate resources from four partner universities: Manchester, Sheffield, Lancaster, and Liverpool.

Supported in part by the Clatterbridge Cancer Research Trust, this hub will conduct tumor sequencing studies, and will pursue research into genetic susceptibility and personalized medicine.

In a separate announcement, the Babraham Institute said today that it is using its £1.65 million ($2.5 million) grant to start a genome sequencing facility through a partnership with the University of Cambridge's Centre for Trophoblast Research. Funding for this center came from MRC and from the Biotechnology and Biological Sciences Research Council.

"There is a pressing need to understand the basis of genetic variation and to use it to define the most appropriate treatment for each patient with a particular condition," Professor Neil Hall, of the School of Biological Sciences and a principal investigator at the North of England hub, said in a statement. "Such research will benefit greatly from the new hub in the North of England by allowing much more productive sequencing technologies to be made available across the research community."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.